✦ LIBER ✦

Keynote comment: Reimbursement for molecularly targeted anticancer agents

✍ Scribed by Umberto Tirelli; Gilberto de Castro Jr; Ahmad Awada

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Strategies for optimizing combinations o

✍ Dancey, Janet E.; Chen, Helen X. 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 335 KB

Current challenges for the early clinica

✍ Christophe Le Tourneau; Véronique Diéras; Patricia Tresca; Wulfran Cacheux; Xavi 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 148 KB

Preclinical evaluation of molecular-targ

✍ Mechthild Krause; Daniel Zips; Howard D. Thames; Johann Kummermehr; Michael Baum 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 267 KB

ST1571: a paradigm for clinical trials o

✍ B.J Druker 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 18 KB

Clinical Trial Design for Target Specifi

✍ Ronald Hoekstra; Jaap Verweij; Ferry A.L.M. Eskens 📂 Article 📅 2003 🏛 Springer US 🌐 English ⚖ 90 KB

Supramolecular approach for target trans

✍ Kejík, Zdeněk; Kaplánek, Robert; Bříza, Tomáš; Králová, Jarmila; Martásek, Pavel 📂 Article 📅 2012 🏛 Taylor and Francis Group 🌐 English ⚖ 520 KB